Gaudium IVF & Women Health IPO Details
MAINBOARD
Gaudium IVF & Women Health IPO DRHP (Draft Red Herring Prospectus) has been SEBI Approval Received.
Offer for Sale consists of 25,31,700 shares (aggregating up to ₹0.00 Cr.). Pre-issue shareholding stands at 6,13,94,384, which will increase to 7,97,48,784 post-issue.
The Lead Managers for Gaudium IVF & Women Health IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Sarthi Capital Advisors Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Gaudium IVF & Women Health Limited DRHP.
Gaudium IVF & Women Health IPO Details
Gaudium IVF & Women Health IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
To be announced | |||
Gaudium IVF & Women Health IPO Reservation
Promoter Holding
Documents
Gaudium IVF & Women Health IPO Valuations
Gaudium IVF & Women Health Financial Information
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 72.27 | 57.29 | 36.63 | 17.77 |
| Total Income | 31.7 | 53.75 | 44.26 | 36.52 |
| Profit After Tax | 8.14 | 16.6 | 13.52 | 8.83 |
| Net Worth | 41.55 | 33.27 | 22.73 | 9.29 |
| Total Borrowing | 19.48 | 15.73 | 9.78 | 5.95 |
| Amount in ₹ Crore | ||||
About Gaudium IVF & Women Health IPO
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India and have expanded into several states utilizing a hub-and-spoke model.
The company operates over thirty locations, which include seven hubs (centres) and twenty-eight spokes. The organization has entered into a strategic alliance with Infertility Experts, known as Spokes, to achieve the mutual objective of raising awareness regarding Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) treatments.
The company serves patients from various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company has centres in major cities: two in Delhi (Janakpuri, Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore, covering key locations across India.
The company offers specialized fertility services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction. Our treatments are designed for various infertility challenges for both genders. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis, as well as high-risk pregnancy management for women with complex fertility histories or health conditions.
- Patient-Centric Approach
-
Focus on healthcare for underprivileged communities
- Using next-gen INTEGRA Ti labs for ICSI.
-
Highly Technical USG Guided Services
- Established central hubs in prime urban locations, including Mumbai, Bangalore, Delhi NCR, and Patna.
Strength Of Gaudium IVF & Women Health IPO
Risk Of Gaudium IVF & Women Health IPO
Objectives Gaudium IVF & Women Health IPO
1. Funding capital expenditure towards establishment of New IVF Centers of the Company
2. Funding working capital requirements for the establishment of New IVF Centers
3. Investment in our Wholly Owned Subsidiary(WOS), EKK Global Private Limited for: a)Launching of FMCG products; and b)Funding its Working Capital Requirements
4. General Corporate Purpose
Company Contact Details
Gaudium IVF & Women Health Ltd.
B1/51,
Janak Puri,
B-1,
New Delhi, New Delhi, 110058
Phone: 011-4885 8585
Email: compliance@gaudiumivfcentre.com
Website: https://www.gaudiumivfcentre.com/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Gaudium IVF & Women Health IPO - FAQs
The Gaudium IVF & Women Health IPO is a MAINBOARD public issue comprising 0 equity shares with a face value of ₹5 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.
The IPO opens for subscription on TBA, and closes on TBA.
Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at TBA.